Aclaris CEO Bags 274,800 RSUs in Bold Long‑Term Bet Amid Stock Volatility Flash Report
Insider buying at Aclaris Therapeutics shows CEO Walker Neal’s confidence—an RSU grant signals long‑term commitment amid market volatility.
4 minutes to read
Aclaris Therapeutics Inc
Aclaris CEO‑Level Insider Buys Nearly 21,000 Shares—Signals Confidence Amid Profit Woes
Loerop James’ recent bulk purchase of Aclaris Therapeutics shares signals insider confidence, but investors should weigh the company’s earnings challenges and upcoming milestones before acting.
4 minutes to read